Bank of America
FBLG icon

Bank of America’s FibroBiologics FBLG Stock Holding History

Bank of America’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,409
Closed -$10.8K – 6973
2025
Q4 		$10.8K Hold
2,409
– – ﹤0.01% 6149
2025
Q3 		$26.3K Buy
2,409
+21
+0.9% +$251 ﹤0.01% 7012
2025
Q2 		$29.7K Sell
2,388
-2,214
-48% -$39.9K ﹤0.01% 6959
2025
Q1 		$82.8K Buy
4,602
+109
+2% +$3.11K ﹤0.01% 6576
2024
Q4 		$180K Sell
4,493
-373
-8% -$20K ﹤0.01% 6166
2024
Q3 		$301K Buy
4,866
+839
+21% +$55.8K ﹤0.01% 5804
2024
Q2 		$402K Buy
+4,027
New +$768K ﹤0.01% 5475

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM